BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8406590)

  • 1. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.
    Huemer HP; Wang Y; Garred P; Koistinen V; Oppermann S
    Immunology; 1993 Aug; 79(4):639-47. PubMed ID: 8406590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
    Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
    Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
    McNearney TA; Odell C; Holers VM; Spear PG; Atkinson JP
    J Exp Med; 1987 Nov; 166(5):1525-35. PubMed ID: 2824652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component.
    Lambris JD; Lao Z; Oglesby TJ; Atkinson JP; Hack CE; Becherer JD
    J Immunol; 1996 Jun; 156(12):4821-32. PubMed ID: 8648130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.
    Friedman HM; Glorioso JC; Cohen GH; Hastings JC; Harris SL; Eisenberg RJ
    J Virol; 1986 Nov; 60(2):470-5. PubMed ID: 3021981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
    Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
    Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.
    Huemer HP; Larcher C; Dierich MP; Falke D
    Arch Virol; 1992; 127(1-4):291-303. PubMed ID: 1333754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the C3b receptor-binding domain in third component of complement.
    Becherer JD; Lambris JD
    J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells.
    Friedman HM; Cohen GH; Eisenberg RJ; Seidel CA; Cines DB
    Nature; 1984 Jun 14-20; 309(5969):633-5. PubMed ID: 6328323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells.
    Schwendinger MG; Spruth M; Schoch J; Dierich MP; Prodinger WM
    J Immunol; 1997 Jun; 158(11):5455-63. PubMed ID: 9164968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2.
    Seidel-Dugan C; Ponce de Leon M; Friedman HM; Fries LF; Frank MM; Cohen GH; Eisenberg RJ
    J Virol; 1988 Nov; 62(11):4027-36. PubMed ID: 2845122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
    Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus glycoprotein C is a receptor for complement component iC3b.
    Tal-Singer R; Seidel-Dugan C; Fries L; Huemer HP; Eisenberg RJ; Cohen GH; Friedman HM
    J Infect Dis; 1991 Oct; 164(4):750-3. PubMed ID: 1654359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of the complement receptor glycoprotein C from Herpesvirus simiae (herpes B virus): protection from complement-mediated cell lysis.
    Huemer HP; Wechselberger C; Bennett AM; Falke D; Harrington L
    J Gen Virol; 2003 May; 84(Pt 5):1091-1100. PubMed ID: 12692273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.
    Friedman HM; Wang L; Pangburn MK; Lambris JD; Lubinski J
    J Immunol; 2000 Oct; 165(8):4528-36. PubMed ID: 11035093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.